Question 1

What is the catalog number for 4-Nitrophenyl 2- (Acetamido) -2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranoside?

Accepted Answer

The catalog number for 4-Nitrophenyl 2- (Acetamido) -2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranoside is sc-478158.

Question 2

What sizes are available for 4-Nitrophenyl 2- (Acetamido) -2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranoside?

Accepted Answer

4-Nitrophenyl 2- (Acetamido) -2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranoside is available in the following size(s): 2.5 mg.

Question 3

Is 4-Nitrophenyl 2- (Acetamido) -2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranoside in stock?

Accepted Answer

4-Nitrophenyl 2- (Acetamido) -2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranoside is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

4-Nitrophenyl 2- (Acetamido) -2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranoside

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Anti-S100 beta/S100B Antibody Picoband®, HRP Conjugate

CD7 (T3-3A1), CF568 conjugate, 0.1mg/mL

CD31 / PECAM-1 (C31.7), CF568 conjugate, 0.1mg/mL

BTLA (BTLA/1528), 1mg/mL

CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Biotin conjugate, 0.1mg/mL